Aspen Australia has advised
new conditions concerning
prescribing and dispensing Di-Gesic
(dextropropoxyphene HCL) and
Doloxene (dextropropoxyphene
napsylate).
The conditions came into effect
on 01 Jan.
Doctors need to complete a
Prescriber Confirmation Form for
all new prescriptions written after
01 Jan.
Audit and pharmacy copies need
to be presented with the script to
the pharmacy before dispensation.
“Pharmacists should not dispense
an original script without the
Prescriber Confirmation Form,”
said Aspen, “even if the script was
written prior to 1 January 2014.
“Repeat prescriptions do not
require a Prescriber Confirmation
Form, regardless of when they were
first dispensed.”
The Therapeutic Goods
Administration has posted a handy
dextropropoxyphene Q&A section
on their website (PD yesterday).
For more, CLICK HERE.The above article was sent to subscribers in Pharmacy Daily's issue from 09 Jan 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Jan 14
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
A NEW study from the University of South Australia has discovered that an increased cardio-fitness level will reduce risk of death from any cause by nearly 20%.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.